ACADIA Pharmaceuticals Inc.
(NASDAQ : ACAD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.39%183.701.1%$863.52m
GILDGilead Sciences, Inc.
-0.40%80.620.9%$826.98m
CELGCelgene Corporation
1.00%94.791.2%$768.50m
JUNOJuno Therapeutics, Inc.
1.96%86.6513.5%$580.24m
BIIBBiogen Inc.
0.33%288.401.2%$511.63m
REGNRegeneron Pharmaceuticals, Inc.
-1.22%319.092.7%$395.84m
VRTXVertex Pharmaceuticals Incorporated
-1.56%158.481.9%$353.78m
ALXNAlexion Pharmaceuticals, Inc.
-0.53%118.222.0%$255.26m
NKTRNektar Therapeutics
1.57%84.766.0%$250.93m
ILMNIllumina, Inc.
0.13%226.863.5%$231.01m
BLUEBluebird Bio, Inc.
2.17%209.9016.1%$196.11m
AAgilent Technologies, Inc.
1.46%72.121.5%$178.17m
INCYIncyte Corporation
0.39%85.842.5%$154.71m
BMRNBioMarin Pharmaceutical Inc.
1.09%84.764.4%$122.49m
EXASExact Sciences Corporation
-0.23%47.9026.0%$117.89m

Company Profile

ACADIA Pharmaceuticals, Inc. engages in the research, development and manufacture of pharmaceutical products. It focuses on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.